Global Pharmaceutical Contract Sales Organization (CSO) Market Growth (Status and Outlook) 2022-2028
- Category: Internet & Telecom
- Published Date: Jan 2023
- Publisher: LP Information
- Pages: 111
provides a series of services and solutions related to pharmaceutical marketing and sales activities under contracts with pharmaceutical or biotech companies. The use of CSOs is an indispensable strategic option in the constantly changing pharmaceutical industry.
The global market for Pharmaceutical Contract Sales Organization (CSO) is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pharmaceutical Contract Sales Organization (CSO) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pharmaceutical Contract Sales Organization (CSO) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pharmaceutical Contract Sales Organization (CSO) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pharmaceutical Contract Sales Organization (CSO) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pharmaceutical Contract Sales Organization (CSO) players cover China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA and Ashfield Engage (Inizio), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pharmaceutical Contract Sales Organization (CSO) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pharmaceutical Contract Sales Organization (CSO) market, with both quantitative and qualitative data, to help readers understand how the Pharmaceutical Contract Sales Organization (CSO) market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Pharmaceutical Contract Sales Organization (CSO) market and forecasts the market size by Type (Personal Promotion, Non-Personal Promotion and Others), by Application (Pharmaceutical Company, Biotechnology Company, Generic Company and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Personal Promotion
Non-Personal Promotion
Others
Segmentation by application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
Chapter Introduction
Chapter 1: Scope of Pharmaceutical Contract Sales Organization (CSO), Research Methodology, etc.
Chapter 2: Executive Summary, global Pharmaceutical Contract Sales Organization (CSO) market size and CAGR, Pharmaceutical Contract Sales Organization (CSO) market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pharmaceutical Contract Sales Organization (CSO) revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pharmaceutical Contract Sales Organization (CSO) revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pharmaceutical Contract Sales Organization (CSO) market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health and EPS Corporation, etc.
Chapter 14: Research Findings and Conclusion
The global market for Pharmaceutical Contract Sales Organization (CSO) is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pharmaceutical Contract Sales Organization (CSO) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pharmaceutical Contract Sales Organization (CSO) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pharmaceutical Contract Sales Organization (CSO) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pharmaceutical Contract Sales Organization (CSO) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pharmaceutical Contract Sales Organization (CSO) players cover China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA and Ashfield Engage (Inizio), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pharmaceutical Contract Sales Organization (CSO) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pharmaceutical Contract Sales Organization (CSO) market, with both quantitative and qualitative data, to help readers understand how the Pharmaceutical Contract Sales Organization (CSO) market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Pharmaceutical Contract Sales Organization (CSO) market and forecasts the market size by Type (Personal Promotion, Non-Personal Promotion and Others), by Application (Pharmaceutical Company, Biotechnology Company, Generic Company and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Personal Promotion
Non-Personal Promotion
Others
Segmentation by application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
Chapter Introduction
Chapter 1: Scope of Pharmaceutical Contract Sales Organization (CSO), Research Methodology, etc.
Chapter 2: Executive Summary, global Pharmaceutical Contract Sales Organization (CSO) market size and CAGR, Pharmaceutical Contract Sales Organization (CSO) market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pharmaceutical Contract Sales Organization (CSO) revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pharmaceutical Contract Sales Organization (CSO) revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pharmaceutical Contract Sales Organization (CSO) market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health and EPS Corporation, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Contract Sales Organization (CSO) Market Size 2017-2028
2.1.2 Pharmaceutical Contract Sales Organization (CSO) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pharmaceutical Contract Sales Organization (CSO) Segment by Type
2.2.1 Personal Promotion
2.2.2 Non-Personal Promotion
2.2.3 Others
2.3 Pharmaceutical Contract Sales Organization (CSO) Market Size by Type
2.3.1 Pharmaceutical Contract Sales Organization (CSO) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Market Share by Type (2017-2022)
2.4 Pharmaceutical Contract Sales Organization (CSO) Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.4.3 Generic Company
2.4.4 Others
2.5 Pharmaceutical Contract Sales Organization (CSO) Market Size by Application
2.5.1 Pharmaceutical Contract Sales Organization (CSO) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Market Share by Application (2017-2022)
3 Pharmaceutical Contract Sales Organization (CSO) Market Size by Player
3.1 Pharmaceutical Contract Sales Organization (CSO) Market Size Market Share by Players
3.1.1 Global Pharmaceutical Contract Sales Organization (CSO) Revenue by Players (2020-2022)
3.1.2 Global Pharmaceutical Contract Sales Organization (CSO) Revenue Market Share by Players (2020-2022)
3.2 Global Pharmaceutical Contract Sales Organization (CSO) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Contract Sales Organization (CSO) by Regions
4.1 Pharmaceutical Contract Sales Organization (CSO) Market Size by Regions (2017-2022)
4.2 Americas Pharmaceutical Contract Sales Organization (CSO) Market Size Growth (2017-2022)
4.3 APAC Pharmaceutical Contract Sales Organization (CSO) Market Size Growth (2017-2022)
4.4 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Growth (2017-2022)
4.5 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2017-2022)
5.2 Americas Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2017-2022)
5.3 Americas Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Contract Sales Organization (CSO) Market Size by Region (2017-2022)
6.2 APAC Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2017-2022)
6.3 APAC Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Contract Sales Organization (CSO) by Country (2017-2022)
7.2 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2017-2022)
7.3 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) by Region (2017-2022)
8.2 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2017-2022)
8.3 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.1 Global Pharmaceutical Contract Sales Organization (CSO) Forecast by Regions (2023-2028)
10.1.1 Global Pharmaceutical Contract Sales Organization (CSO) Forecast by Regions (2023-2028)
10.1.2 Americas Pharmaceutical Contract Sales Organization (CSO) Forecast
10.1.3 APAC Pharmaceutical Contract Sales Organization (CSO) Forecast
10.1.4 Europe Pharmaceutical Contract Sales Organization (CSO) Forecast
10.1.5 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Forecast
10.2 Americas Pharmaceutical Contract Sales Organization (CSO) Forecast by Country (2023-2028)
10.2.1 United States Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.2.2 Canada Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.2.3 Mexico Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.2.4 Brazil Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3 APAC Pharmaceutical Contract Sales Organization (CSO) Forecast by Region (2023-2028)
10.3.1 China Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.2 Japan Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.3 Korea Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.4 Southeast Asia Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.5 India Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.6 Australia Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4 Europe Pharmaceutical Contract Sales Organization (CSO) Forecast by Country (2023-2028)
10.4.1 Germany Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4.2 France Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4.3 UK Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4.4 Italy Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4.5 Russia Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Forecast by Region (2023-2028)
10.5.1 Egypt Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5.2 South Africa Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5.3 Israel Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5.4 Turkey Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5.5 GCC Countries Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.6 Global Pharmaceutical Contract Sales Organization (CSO) Forecast by Type (2023-2028)
10.7 Global Pharmaceutical Contract Sales Organization (CSO) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 China Medical System (CMS)
11.1.1 China Medical System (CMS) Company Information
11.1.2 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 China Medical System (CMS) Main Business Overview
11.1.5 China Medical System (CMS) Latest Developments
11.2 IQVIA
11.2.1 IQVIA Company Information
11.2.2 IQVIA Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.2.3 IQVIA Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 IQVIA Main Business Overview
11.2.5 IQVIA Latest Developments
11.3 PHOENIX Group
11.3.1 PHOENIX Group Company Information
11.3.2 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.3.3 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 PHOENIX Group Main Business Overview
11.3.5 PHOENIX Group Latest Developments
11.4 EVERSANA
11.4.1 EVERSANA Company Information
11.4.2 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.4.3 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 EVERSANA Main Business Overview
11.4.5 EVERSANA Latest Developments
11.5 Ashfield Engage (Inizio)
11.5.1 Ashfield Engage (Inizio) Company Information
11.5.2 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Ashfield Engage (Inizio) Main Business Overview
11.5.5 Ashfield Engage (Inizio) Latest Developments
11.6 Amplity Health
11.6.1 Amplity Health Company Information
11.6.2 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.6.3 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amplity Health Main Business Overview
11.6.5 Amplity Health Latest Developments
11.7 Sinco Pharma
11.7.1 Sinco Pharma Company Information
11.7.2 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.7.3 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sinco Pharma Main Business Overview
11.7.5 Sinco Pharma Latest Developments
11.8 Syneos Health
11.8.1 Syneos Health Company Information
11.8.2 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.8.3 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Syneos Health Main Business Overview
11.8.5 Syneos Health Latest Developments
11.9 EPS Corporation
11.9.1 EPS Corporation Company Information
11.9.2 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.9.3 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 EPS Corporation Main Business Overview
11.9.5 EPS Corporation Latest Developments
11.10 Uniphar Group
11.10.1 Uniphar Group Company Information
11.10.2 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.10.3 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Uniphar Group Main Business Overview
11.10.5 Uniphar Group Latest Developments
11.11 CMIC Group
11.11.1 CMIC Group Company Information
11.11.2 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.11.3 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 CMIC Group Main Business Overview
11.11.5 CMIC Group Latest Developments
11.12 SciClone Pharmaceuticals
11.12.1 SciClone Pharmaceuticals Company Information
11.12.2 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 SciClone Pharmaceuticals Main Business Overview
11.12.5 SciClone Pharmaceuticals Latest Developments
11.13 China Pioneer Pharma
11.13.1 China Pioneer Pharma Company Information
11.13.2 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 China Pioneer Pharma Main Business Overview
11.13.5 China Pioneer Pharma Latest Developments
11.14 Promoveo Health
11.14.1 Promoveo Health Company Information
11.14.2 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.14.3 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Promoveo Health Main Business Overview
11.14.5 Promoveo Health Latest Developments
11.15 CSO Pharmitalia
11.15.1 CSO Pharmitalia Company Information
11.15.2 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 CSO Pharmitalia Main Business Overview
11.15.5 CSO Pharmitalia Latest Developments
11.16 GTS Solution
11.16.1 GTS Solution Company Information
11.16.2 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.16.3 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 GTS Solution Main Business Overview
11.16.5 GTS Solution Latest Developments
11.17 QFR Solutions
11.17.1 QFR Solutions Company Information
11.17.2 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.17.3 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 QFR Solutions Main Business Overview
11.17.5 QFR Solutions Latest Developments
12 Research Findings and Conclusion
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Contract Sales Organization (CSO) Market Size 2017-2028
2.1.2 Pharmaceutical Contract Sales Organization (CSO) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pharmaceutical Contract Sales Organization (CSO) Segment by Type
2.2.1 Personal Promotion
2.2.2 Non-Personal Promotion
2.2.3 Others
2.3 Pharmaceutical Contract Sales Organization (CSO) Market Size by Type
2.3.1 Pharmaceutical Contract Sales Organization (CSO) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Market Share by Type (2017-2022)
2.4 Pharmaceutical Contract Sales Organization (CSO) Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.4.3 Generic Company
2.4.4 Others
2.5 Pharmaceutical Contract Sales Organization (CSO) Market Size by Application
2.5.1 Pharmaceutical Contract Sales Organization (CSO) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pharmaceutical Contract Sales Organization (CSO) Market Size Market Share by Application (2017-2022)
3 Pharmaceutical Contract Sales Organization (CSO) Market Size by Player
3.1 Pharmaceutical Contract Sales Organization (CSO) Market Size Market Share by Players
3.1.1 Global Pharmaceutical Contract Sales Organization (CSO) Revenue by Players (2020-2022)
3.1.2 Global Pharmaceutical Contract Sales Organization (CSO) Revenue Market Share by Players (2020-2022)
3.2 Global Pharmaceutical Contract Sales Organization (CSO) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Contract Sales Organization (CSO) by Regions
4.1 Pharmaceutical Contract Sales Organization (CSO) Market Size by Regions (2017-2022)
4.2 Americas Pharmaceutical Contract Sales Organization (CSO) Market Size Growth (2017-2022)
4.3 APAC Pharmaceutical Contract Sales Organization (CSO) Market Size Growth (2017-2022)
4.4 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size Growth (2017-2022)
4.5 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2017-2022)
5.2 Americas Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2017-2022)
5.3 Americas Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Contract Sales Organization (CSO) Market Size by Region (2017-2022)
6.2 APAC Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2017-2022)
6.3 APAC Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Contract Sales Organization (CSO) by Country (2017-2022)
7.2 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2017-2022)
7.3 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) by Region (2017-2022)
8.2 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Type (2017-2022)
8.3 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.1 Global Pharmaceutical Contract Sales Organization (CSO) Forecast by Regions (2023-2028)
10.1.1 Global Pharmaceutical Contract Sales Organization (CSO) Forecast by Regions (2023-2028)
10.1.2 Americas Pharmaceutical Contract Sales Organization (CSO) Forecast
10.1.3 APAC Pharmaceutical Contract Sales Organization (CSO) Forecast
10.1.4 Europe Pharmaceutical Contract Sales Organization (CSO) Forecast
10.1.5 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Forecast
10.2 Americas Pharmaceutical Contract Sales Organization (CSO) Forecast by Country (2023-2028)
10.2.1 United States Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.2.2 Canada Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.2.3 Mexico Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.2.4 Brazil Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3 APAC Pharmaceutical Contract Sales Organization (CSO) Forecast by Region (2023-2028)
10.3.1 China Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.2 Japan Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.3 Korea Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.4 Southeast Asia Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.5 India Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.3.6 Australia Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4 Europe Pharmaceutical Contract Sales Organization (CSO) Forecast by Country (2023-2028)
10.4.1 Germany Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4.2 France Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4.3 UK Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4.4 Italy Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.4.5 Russia Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Forecast by Region (2023-2028)
10.5.1 Egypt Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5.2 South Africa Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5.3 Israel Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5.4 Turkey Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.5.5 GCC Countries Pharmaceutical Contract Sales Organization (CSO) Market Forecast
10.6 Global Pharmaceutical Contract Sales Organization (CSO) Forecast by Type (2023-2028)
10.7 Global Pharmaceutical Contract Sales Organization (CSO) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 China Medical System (CMS)
11.1.1 China Medical System (CMS) Company Information
11.1.2 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.1.3 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 China Medical System (CMS) Main Business Overview
11.1.5 China Medical System (CMS) Latest Developments
11.2 IQVIA
11.2.1 IQVIA Company Information
11.2.2 IQVIA Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.2.3 IQVIA Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 IQVIA Main Business Overview
11.2.5 IQVIA Latest Developments
11.3 PHOENIX Group
11.3.1 PHOENIX Group Company Information
11.3.2 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.3.3 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 PHOENIX Group Main Business Overview
11.3.5 PHOENIX Group Latest Developments
11.4 EVERSANA
11.4.1 EVERSANA Company Information
11.4.2 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.4.3 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 EVERSANA Main Business Overview
11.4.5 EVERSANA Latest Developments
11.5 Ashfield Engage (Inizio)
11.5.1 Ashfield Engage (Inizio) Company Information
11.5.2 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.5.3 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Ashfield Engage (Inizio) Main Business Overview
11.5.5 Ashfield Engage (Inizio) Latest Developments
11.6 Amplity Health
11.6.1 Amplity Health Company Information
11.6.2 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.6.3 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amplity Health Main Business Overview
11.6.5 Amplity Health Latest Developments
11.7 Sinco Pharma
11.7.1 Sinco Pharma Company Information
11.7.2 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.7.3 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sinco Pharma Main Business Overview
11.7.5 Sinco Pharma Latest Developments
11.8 Syneos Health
11.8.1 Syneos Health Company Information
11.8.2 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.8.3 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Syneos Health Main Business Overview
11.8.5 Syneos Health Latest Developments
11.9 EPS Corporation
11.9.1 EPS Corporation Company Information
11.9.2 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.9.3 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 EPS Corporation Main Business Overview
11.9.5 EPS Corporation Latest Developments
11.10 Uniphar Group
11.10.1 Uniphar Group Company Information
11.10.2 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.10.3 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Uniphar Group Main Business Overview
11.10.5 Uniphar Group Latest Developments
11.11 CMIC Group
11.11.1 CMIC Group Company Information
11.11.2 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.11.3 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 CMIC Group Main Business Overview
11.11.5 CMIC Group Latest Developments
11.12 SciClone Pharmaceuticals
11.12.1 SciClone Pharmaceuticals Company Information
11.12.2 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.12.3 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 SciClone Pharmaceuticals Main Business Overview
11.12.5 SciClone Pharmaceuticals Latest Developments
11.13 China Pioneer Pharma
11.13.1 China Pioneer Pharma Company Information
11.13.2 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.13.3 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 China Pioneer Pharma Main Business Overview
11.13.5 China Pioneer Pharma Latest Developments
11.14 Promoveo Health
11.14.1 Promoveo Health Company Information
11.14.2 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.14.3 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Promoveo Health Main Business Overview
11.14.5 Promoveo Health Latest Developments
11.15 CSO Pharmitalia
11.15.1 CSO Pharmitalia Company Information
11.15.2 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.15.3 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 CSO Pharmitalia Main Business Overview
11.15.5 CSO Pharmitalia Latest Developments
11.16 GTS Solution
11.16.1 GTS Solution Company Information
11.16.2 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.16.3 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 GTS Solution Main Business Overview
11.16.5 GTS Solution Latest Developments
11.17 QFR Solutions
11.17.1 QFR Solutions Company Information
11.17.2 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Product Offered
11.17.3 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 QFR Solutions Main Business Overview
11.17.5 QFR Solutions Latest Developments
12 Research Findings and Conclusion
no record found